Nav: Home

Method identified to boost detection of highly cancerous stem cells

March 30, 2017

Japanese researchers identify process to improve fluorescence detection of cancer stem cells, which are primarily responsible for brain tumor progression and recurrence after treatment

Tokyo - Photodynamic detection and therapy has recently emerged as a promising approach for diagnosing and treating cancer. With this process, patients are given a chemical metabolized specifically in tumor cells so that it becomes fluorescent, allowing visual identification and surgical removal of the tumor.

Complete removal of all cancerous cells is crucial, as any residual cells can cause tumor recurrence. However, tumors are made up of a variety of different cell types, and it has been unclear whether photodynamic detection identifies all of them. Cancer stem cells, a type of self-renewing cell found in tumors, are of particular interest because they are the main cell type responsible for tumor progression and for resistance to chemotherapy and radiotherapy, and therefore a major cause of tumor recurrence after treatment. Assessing and optimizing photodynamic detection for cancer stem cell detection is vital to the approach's success.

In a new study published in Scientific Reports, Tokyo Medical and Dental University (TMDU)-led researchers investigated photodynamic detection of cancer stem cells in a glioma cell line, a model of a highly aggressive type of brain cancer. They identified a subpopulation of glioma stem cells, which, unlike most glioma cells, did not accumulate substantial amounts of fluorescent product during photodynamic detection. When transplanted into immunosuppressed mice, these low-fluorescence stem cells rapidly formed tumors, whereas high-fluorescence stem cells did not.

"This is a clear problem for photodynamic detection," corresponding author Tetsuya Taga says. "The cells that escape detection are the ones that, if not removed, are the most likely to result in treatment failing and a tumor recurring. By increasing fluorescence in these cells, we could substantially improve the success of fluorescence detection and tumor removal."

The researchers went on to investigate possible mechanisms for, and solutions to, low fluorescence levels. Iron is required to break down the fluorescent material in cells, so they explored chelating iron (binding it to prevent it from participating in this process).

"We were able to boost fluorescence accumulation in the highly tumorigenic low-fluorescence glioma stem cell subpopulation using a clinically approved iron chelator," co-corresponding author Kouichi Tabu says. "This is particularly exciting because it means this new method has potential to rapidly translate to clinical practice."

Further investigation of the metabolic pathway that breaks down the fluorescent material revealed a gene, heme oxygenase-1 (HO-1), that may be responsible for the differences in fluorescence. Targeting HO-1 is therefore another potential approach to improving photodynamic detection in human glial cell cancers.
-end-
The article, "Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation" was published in Scientific Reports at DOI:10.1038/srep42070

Tokyo Medical and Dental University

Related Brain Cancer Articles:

AI may help brain cancer patients avoid biopsy
Brain cancer patients in the coming years may not need to go under the knife to help doctors determine the best treatment for their tumors.
Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.
Finding new clues to brain cancer treatment
Researchers at Case Western Reserve University School of Medicine and Cleveland Clinic new discovered a more accurate way to determine the relative life expectancy of glioblastoma victims and identify who could be candidates for experimental clinical drug trials by blending information from Artificial Intelligence (AI)--in this case, computer image analysis of the initial MRI scans taken of brain cancer patients--and genomic research.
Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain
Effective drug delivery through the BTB is one of the greatest therapeutic obstacles in treating brain metastases.
Blood test could help to accelerate brain cancer diagnosis
A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde.
The 'Goldilocks' principle for curing brain cancer
University of Minnesota Medical School researchers found that a stable body temperature holds the key to awakening the body's immune response to fight off brain cancer.
The path of breast-to-brain cancer metastasis
Scientists at EPFL's Swiss Institute for Experimental Cancer Research have discovered a signaling pathway that breast tumors exploit to metastasize to the brain.
How breast cancer uses exosomes to metastasize to the brain
In breast cancer, metastases to the brain often spell a death sentence; many women survive for less than a year after diagnosis.
New hope for treating childhood brain cancer
Recent research has shown that a drug known as MI-2 can kill cells that cause a fatal brain cancer.
Helping infants survive brain cancer
Choroid plexus carcinoma (CPC) is a particularly challenging type of brain cancer: The tumor most commonly arises in infants under the age of one.
More Brain Cancer News and Brain Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.